| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.760 | 25.396 | 30.357 | 28.776 | 30.065 | 27.496 | 114.621 | 165.569 | 180.068 | 190.976 |
| Total Income - EUR | 24.877 | 26.036 | 30.382 | 28.776 | 30.270 | 27.496 | 114.711 | 165.742 | 180.068 | 192.089 |
| Total Expenses - EUR | 21.645 | 22.625 | 26.450 | 26.207 | 27.350 | 29.295 | 97.489 | 129.344 | 141.531 | 145.987 |
| Gross Profit/Loss - EUR | 3.232 | 3.411 | 3.932 | 2.569 | 2.919 | -1.800 | 17.222 | 36.397 | 38.537 | 46.102 |
| Net Profit/Loss - EUR | 1.954 | 3.161 | 3.629 | 2.282 | 2.616 | -1.965 | 16.179 | 34.989 | 37.006 | 41.315 |
| Employees | 2 | 2 | 0 | 2 | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Pro Med Vita Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 727 | 667 | 605 | 447 | 389 | 334 | 279 | 921 | 438 | 1.648 |
| Current Assets | 6.449 | 8.992 | 12.291 | 13.440 | 16.054 | 13.854 | 33.885 | 65.967 | 91.952 | 105.806 |
| Inventories | 1.626 | 2.799 | 4.078 | 3.925 | 6.344 | 7.164 | 11.569 | 20.408 | 35.456 | 57.292 |
| Receivables | 447 | 1.035 | 1.017 | 1.407 | 4.163 | 2.080 | 2.617 | 2.648 | 2.353 | 3.562 |
| Cash | 4.375 | 5.159 | 7.196 | 8.108 | 5.547 | 4.610 | 19.699 | 42.911 | 54.144 | 44.952 |
| Shareholders Funds | 4.526 | 7.573 | 11.030 | 12.152 | 14.533 | 12.292 | 24.944 | 58.164 | 78.518 | 89.238 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.649 | 2.086 | 1.866 | 1.735 | 1.910 | 1.895 | 9.220 | 8.724 | 13.873 | 18.216 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Pro Med Vita Srl